|
BAY-218
|
CPD3504
|
2162982-11-6
|
|
vanin-1 inhibitor
|
|
2173134-00-2
|
|
Danicopan
|
|
1903768-17-1
|
|
AB-928
|
|
2239273-34-6
|
|
AT-007
|
|
2170729-29-8
|
|
GS-4361
|
|
2291164-02-6
|
|
PF-06835919
|
|
2102501-84-6
|
|
LML-134
|
|
1542135-76-1
|
|
EC-5026
|
|
1809885-32-2
|
|
BMS-615
|
|
2180127-82-4
|
|
VU6015929
|
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]-
|
2442597-56-8
|
|
Tavapadon
|
他伐帕敦
|
1643489-24-0
|
|
NTP-42
|
|
2055599-51-2
|
|
suvn-911
|
化合物SUVN-911
|
2414674-71-6
|
|
SR-4835
|
|
2387704-62-1
|
|
Vonafexor
|
YP001
|
1192171-69-9
|
|
BAY 2416964
|
AHR antagonist 3
|
2242464-44-2
|
|
MDR652
|
化合物MDR-652
|
1933528-96-1
|
|
DS-1971a
|
|
1450595-86-4
|
|
EST73502 hydrochloride
|
化合物EST73502 HCL
|
2307458-82-6
|
|
PK68
|
|
2173556-69-7
|
|
Mivacurium chloride
|
米库氯铵
|
106861-44-3
|
|
Alendronic Acid-d6
|
阿仑膦酸-D6氘代
|
1035437-39-8
|
|
Gadobutrol Impurity 63
|
1,3-Dioxepan-5-ol, 6-bromo-2,2-dimethyl- (9CI)
|
909195-13-7
|
|
sodium 5-hydroxypentanoate
|
5-羟基戊酸钠
|
37435-69-1
|
|
Seltorexant
|
JNJ-42847922
|
1293281-49-8
|
|
Rineterkib
|
ERK-IN-1 (COMPOUND B)
|
1715025-32-3
|
|
Emavusertib
|
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
|
1801344-14-8
|
|
CC90001
|
|
1403859-14-2
|
|
2-(3,4,5-trimethoxyphenyl)acetamide
|
3,4,5-三甲氧基苯乙酰胺
|
91248-14-5
|
|
Baclofen-d4
|
巴氯芬-D4
|
1189938-30-4
|
|
Licogliflozin
|
1291094-73-9
|
1291094-73-9
|
|
PXS5505 HCl
|
PXS-5505二盐酸盐
|
2409964-23-2
|
|
ACH-000143
|
化合物ACH-000143
|
2225836-30-4
|
|
XL092
|
|
2367004-54-2
|
|
SHR0302
|
化合物SHR0302
|
1445987-21-2
|
|
AB-680
|
|
2105904-82-1
|
|
IACS-13909
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
|
AZD5305
|
AZD-5305
|
2589531-76-8
|
|
BMS-986242
|
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
|
1923844-48-7
|
|
PF-9363
|
|
2569009-58-9
|
|
GLPG2938
|
|
2130996-00-6
|
|
MIPS-521
|
|
1146188-19-3
|
|
Lu AF27139
|
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF
|
2097117-06-9
|
|
KL11743
|
|
1369452-53-8
|
|
AMP-945
|
|
1393653-34-3
|
|
YTX-465
|
|
2225824-53-1
|
|
SCD1 inhibitor-3
|
化合物SCD1 INHIBITOR-3
|
1282606-48-7
|
|
ML339
|
化合物ML339
|
2579689-83-9
|
|
Ximelagatran
|
希美加群
|
192939-46-1
|
|
Bocidelpar
|
化合物BOCIDELPAR
|
2095128-20-2
|
|
SR1664
|
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid
|
1338259-05-4
|
|
Complement factor D-IN-2
|
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)-
|
1903742-34-6
|
|
Methyltetrazine-NHS ester
|
|
1644644-96-1
|
|
KN-62
|
1-[N,O-二(5-异喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪
|
127191-97-3
|
|
SKF89976A hydrochloride
|
1 - (4,4 - 二苯基-3 - 丁烯基)- 3 -哌啶盐酸盐
|
85375-15-1
|
|
RY785
|
|
1393748-80-5
|
|
JQKD-82
|
|
2410512-38-6
|
|
GSK251
|
|
2125968-05-8
|
|
SU16f
|
化合物 T16947
|
251356-45-3
|
|
Ro 60-0175
|
|
169675-08-5
|
|
1,4-dibromo-2-methylbut-2-ene
|
1,4-二溴-2-甲基-2-丁烯
|
18860-95-2
|
|
Baloxavir Impurity 23
|
BALOXAVIR
|
1985607-68-8
|
|
Baloxavir Impurity 24
|
巴洛沙韦酯杂质29
|
1985607-69-9
|
|
SGK1-IN-4
|
化合物SGK1-IN-4
|
1628048-93-0
|
|
Fexofenadine Impurity 21
|
169032-11-5
|
169032-11-5
|
|
INE963
|
化合物INE963
|
2640567-43-5
|
|
AS2444697
|
AS-2444697
|
1287665-60-4
|
|
CJ033466
|
CJ 033466
|
519148-48-2
|
|
SB-747651A dihydrochloride
|
SB-747651A二盐酸盐
|
1781882-72-1
|
|
NBI-31772
|
NBI-31772 hydrate
|
374620-70-9
|
|
FHD-286
|
|
2671128-05-3
|
|
HBX 41108
|
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
924296-39-9
|
|
Emivirine
|
6-苄基-1-(乙氧基甲基)-5-异丙基尿嘧啶
|
149950-60-7
|
|
CDK4/6-IN-6
|
|
2380321-51-5
|
|
Glutathione synthesis-IN-1
|
化合物GLUTATHIONE SYNTHESIS-IN-1
|
2632968-72-8
|
|
RS 67333 hydrochloride
|
RS 67333盐酸盐
|
168986-60-5
|
|
GLUT inhibitor-1
|
GLUT抑制剂1
|
2421141-40-2
|
|
I-BET567
|
化合物I-BET567
|
1887237-54-8
|
|
SBI-425
|
化合物 T16859
|
1451272-71-1
|
|
GSK329
|
化合物 T24109
|
1268490-12-5
|
|
3-aminooxazolidin-2-one-4,4,5,5-d4
|
硝基呋喃代谢产物-呋喃唑酮AOZ-D4
|
1188331-23-8
|
|
1-aminoimidazolidine-2,4-dione-2,4,5-13C3
|
AHD-13C3
|
957509-31-8
|
|
4-aminoisobenzofuran-1,3-dione
|
1,3-异苯并,4-氨基
|
17395-99-2
|
|
beta-D-Ribofuranose
|
beta-D-Ribofuranose (9CI)
|
36468-53-8
|
|
Uridine Impurity 4
|
尿苷杂质8
|
198267-18-4
|
|
(Z)-3-ureidoacrylic acid
|
Cytarabine Impurity 10
|
84902-98-7
|
|
N-(3-methoxyphenyl)cinnamamide
|
N-(肉桂酰)-3-甲氧基苯胺
|
127033-74-3
|
|
7-methoxyquinolin-2(1H)-one
|
7-甲氧基喹啉-2(1H)-酮
|
23981-26-2
|
|
Levetiracetam Impurity 45
|
左乙拉西坦杂质M
|
2245069-23-0
|
|
4-propylfuran-2(5H)-one
|
4-正丙基呋喃-2(5H)-酮
|
21963-27-9
|
|
Ramosetron Impurity 10
|
4,5,6,7-四氢-1H-苯并咪唑-5-甲酸盐酸盐
|
131020-57-0
|
|
Ramosetron Impurity 9
|
N-[(4,5,6,7-四氢苯并咪唑-5-基)羰基]吡咯硫酸盐
|
132036-42-1
|
|
α-Muurolene
|
|
10208-80-7
|
|
Sparfloxacin
|
司帕沙星
|
110871-86-8
|
|
Isoproterenol Impurity 50
|
异丙肾上腺素杂质50
|
136068-22-9
|
|
(E)-Cinnamoyl Chloride
|
3-苯基-2-丙烯酰氯
|
17082-09-6
|
|
Pirfenidone Impurity 39
|
吡非尼酮杂质D
|
13179-27-6
|
|
Pirfenidone Impurity 40
|
Pirfenidone Impurity 4
|
161057-93-8
|
|
Pirfenidone Impurity 41
|
吡非尼酮杂质H
|
53427-93-3
|